Brokerages have assigned a consensus rating of “Moderate Buy” to BeiGene, Ltd. (NASDAQ:BGNE).
According to Bloomberg, the eight rating agencies following BeiGene, Ltd (NASDAQ: BGNE) have given the company an average "Moderate Buy." ...
Tag: BGNE, Analyst Rating
BlackRock Inc. sells shares of BeiGene, Ltd. (NASDAQ:BGNE).
According to the most recent report that the company has submitted to the Securities and Exchange Commission (SEC), BlackRock INC ...
Tudor Investment Corp and others have purchased shares of BeiGene, Ltd. (NASDAQ:BGNE).
According to the most recent Form 13F filing with the Securities and Exchange Commission that the company submitted, Tudor Investment ...
Nuveen Asset Management LLC has acquired shares of BeiGene, Ltd. (NASDAQ:BGNE).
According to the most recent 13F filing that Nuveen Asset Management LLC submitted to the Securities and Exchange Commission, the ...
Tower Research Capital LLC TRC sells shares of BeiGene, Ltd. (NASDAQ:BGNE).
Tower Research Capital LLC (TRC) disclosed to the Securities and Exchange Commission (SEC) in its most recent filing that the ...
UBS Group AG Increases Its Position in BeiGene, Ltd. (NASDAQ:BGNE)
The most recent Form 13F filing that UBS Group AG made with the Securities and Exchange Commission revealed that during ...
Fairmount Funds Management LLC sells shares of BeiGene, Ltd. (NASDAQ:BGNE).
The most recent 13F filing that Fairmount Funds Management LLC submitted to the Securities and Exchange Commission reveals that during ...
BeiGene, Ltd. is owned by the Manufacturers Life Insurance Company for $2.66 million (NASDAQ:BGNE)
According to the most recent report that the Manufacturers Life Insurance Company submitted to the SEC, the company's holdings in ...
Profund Advisors LLC acquires 519 BeiGene, Ltd. shares (NASDAQ:BGNE)
Profund Advisors LLC increased the percentage of BeiGene, Ltd. (NASDAQ: BGNE) shares that it owned by 5.7% during the third ...
Raymond James & Associates reduces its stake in BeiGene, Ltd. (NASDAQ:BGNE)
Raymond James & Associates decreased its holdings in BeiGene, Ltd. (NASDAQ: BGNE) during the third quarter by 2.8%, as stated ...